Bioservo Technologies AB (publ)

OM:BIOS Stock Report

Market Cap: SEK 1.4m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Bioservo Technologies Future Growth

Future criteria checks 2/6

Bioservo Technologies is forecast to grow revenue at 69.3% per annum.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth20.6%
Revenue growth rate69.3%
Future return on equity6.36%
Analyst coverage

Low

Last updated08 Nov 2023

Recent future growth updates

Recent updates

Analysis Article • Sep 01

Is Bioservo Technologies (STO:BIOS) In A Good Position To Deliver On Growth Plans?

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Analysis Article • Apr 11

Bioservo Technologies (STO:BIOS) Is In A Good Position To Deliver On Growth Plans

Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Analysis Article • Dec 27

We're Not Very Worried About Bioservo Technologies' (STO:BIOS) Cash Burn Rate

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

Earnings and Revenue Growth Forecasts

OM:BIOS - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202558N/A261
12/31/202432N/A-15-131
12/31/202315N/A-39-381
9/30/202312-47-52-51N/A
6/30/202311-48-51-51N/A
3/31/202315-48-52-51N/A
12/31/202214-50-52-51N/A
9/30/202215-43-48-46N/A
6/30/202217-39-40-38N/A
3/31/202213-38-41-39N/A
12/31/202111-35-36-34N/A
9/30/20217-34-30-29N/A
6/30/20215-34-24-23N/A
3/31/202110-28-19-18N/A
12/31/202014-26-18-17N/A
9/30/202022-25-26-25N/A
6/30/202023-24-24-23N/A
3/31/202025-25-25-24N/A
12/31/201924-23-27-26N/A
9/30/201923-27-22-21N/A
6/30/201921-28-32-29N/A
3/31/201917-27-22-19N/A
12/31/201816-28-22-17N/A
9/30/201815-23-22-17N/A
6/30/201814-21-18-13N/A
3/31/201812-22-29-23N/A
12/31/201712-19-22-16N/A
9/30/201711-17-21-15N/A
6/30/201711-16N/A-14N/A
3/31/201712-12N/A-9N/A
12/31/201611-13N/A-13N/A
12/31/201511-7N/AN/AN/A
12/31/20148-4N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if BIOS's forecast earnings growth is above the savings rate (0.8%).

Earnings vs Market: Insufficient data to determine if BIOS's earnings are forecast to grow faster than the Swedish market

High Growth Earnings: Insufficient data to determine if BIOS's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: BIOS's revenue (69.3% per year) is forecast to grow faster than the Swedish market (1.4% per year).

High Growth Revenue: BIOS's revenue (69.3% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: BIOS's Return on Equity is forecast to be low in 3 years time (6.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/01/12 12:04
End of Day Share Price 2024/01/12 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bioservo Technologies AB (publ) is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mats HyttingeCarlsquare AB
Mats HyttingeRedeye